BiopharmaTrend.com

Envisagenics

Envisagenics

Private company
ENVISAGENICS

RNA Splicing Analytics + Artificial Intelligence for Drug Discovery.

Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. Envisagenics is Cold Spring Harbor Laboratory spinout company.


Founded
2014
Status
Private company
Geography
United States of America based
Funding
$4.575 M
Research papers
3

Products

SpliceCore

Artificial Intelligence Platform for Drug Discovery

SpliceCore™ is the Envisagenics cloud-based drug discovery platform that uses RNA data from patients to accelerate R&D therapeutics discovery using …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page